ロード中...
Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer
In recent years, it has become evident that tumor cells have immune escape mechanisms, and immune checkpoint inhibitor therapy (anti-PD-1/PD-L1 antibody) has shown benefit in various cancers. In endometrial tumors with microsatellite-instability (MSI), somatic mutations have the potential to encode...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5814165/ https://ncbi.nlm.nih.gov/pubmed/29464025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23790 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|